2-ethyl-2,4-dimethylbenzo[d][1,3]dioxole | 929302-09-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并间二氧杂环戊烯类
• 英文名称: 2-ethyl-2,4-dimethylbenzo[d][1,3]dioxole
• 英文别名: 2-ethyl-2,4-dimethyl-1,3-benzodioxole
• CAS: 929302-09-0
• 化学式: C₁₁H₁₄O₂
• 分子量: 178.231
• InChiKey: TTYWEVONZFRGAI-UHFFFAOYSA-N

物化性质

• 沸点：
  228.3±30.0 °C(Predicted)
• 密度：
  1.030±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-ethyl-2,4-dimethylbenzo[d][1,3]dioxole 在 calcium hypochlorite 、 sodium carbonate 、 sodium hydroxide 、 zinc(II) chloride 作用下， 以 1,4-二氧六环 、 水 为溶剂， 反应 7.0h， 生成 2-ethyl-2,7-dimethylbenzo[d][1,3]dioxole-5-carboxylic acid
  参考文献：
  名称：

  Enantioselective synthesis of dictyoceratin-A (smenospondiol) and -C, hypoxia-selective growth inhibitors from marine sponge

  摘要：

  Total syntheses of (+)-dictyoceratin-C (1) and (+)-dictyoceratin-A (smenospondiol) (2), hypoxia-selective growth inhibitors isolated from marine sponge, were executed. The absolute stereochemistry of the each compound was determined through the enantioselective total syntheses of them. It revealed that the unnatural enantiomers of them also exhibited the hypoxia-selective growth inhibitory activity against human prostate cancer DU-145 cells. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2015.01.021
• 作为产物：
  描述：

  丁酮 、 3-甲基苯邻二酚 在 四磷十氧化物 作用下， 以 甲苯 为溶剂， 以70%的产率得到2-ethyl-2,4-dimethylbenzo[d][1,3]dioxole
  参考文献：
  名称：

  Enantioselective synthesis of dictyoceratin-A (smenospondiol) and -C, hypoxia-selective growth inhibitors from marine sponge

  摘要：

  Total syntheses of (+)-dictyoceratin-C (1) and (+)-dictyoceratin-A (smenospondiol) (2), hypoxia-selective growth inhibitors isolated from marine sponge, were executed. The absolute stereochemistry of the each compound was determined through the enantioselective total syntheses of them. It revealed that the unnatural enantiomers of them also exhibited the hypoxia-selective growth inhibitory activity against human prostate cancer DU-145 cells. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2015.01.021

文献信息

• NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES
  申请人：Borjesson Lena

  公开号：US20090156575A1

  公开（公告）日：2009-06-18

  The invention provides compounds of general formula wherein A, B, p, w, x, y, and z are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

  本发明提供了一般式为的化合物，其中A、B、p、w、x、y和z的定义如规范中所述，以及其制备方法、包含它们的药物组合物和它们在治疗中的应用。
• WO2007/30061
  申请人：——

  公开号：——

  公开（公告）日：——
• [EN] NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES<br/>[FR] NOUVEAUX DIAZASPIROALCANES ET LEUR UTILISATION POUR LE TRAITEMENT DE MALADIES MEDIEES PAR CCR8
  申请人：ASTRAZENECA AB

  公开号：WO2007030061A1

  公开（公告）日：2007-03-15

  [EN] The invention provides compounds of general formula (I) wherein A, B, p, w, x, y, and z are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
  [FR] L'invention concerne des composés représentés par la formule générale (I) dans laquelle A, B, p, w, x, y et z sont tels que définis dans le descriptif, des procédés de préparation desdits composés, des compositions pharmaceutiques contenant lesdits composés et leur utilisation à des fins thérapeutiques.
• Enantioselective synthesis of dictyoceratin-A (smenospondiol) and -C, hypoxia-selective growth inhibitors from marine sponge
  作者：Yuji Sumii、Naoyuki Kotoku、Akinori Fukuda、Takashi Kawachi、Yuta Sumii、Masayoshi Arai、Motomasa Kobayashi

  DOI：10.1016/j.bmc.2015.01.021

  日期：2015.3

  Total syntheses of (+)-dictyoceratin-C (1) and (+)-dictyoceratin-A (smenospondiol) (2), hypoxia-selective growth inhibitors isolated from marine sponge, were executed. The absolute stereochemistry of the each compound was determined through the enantioselective total syntheses of them. It revealed that the unnatural enantiomers of them also exhibited the hypoxia-selective growth inhibitory activity against human prostate cancer DU-145 cells. (C) 2015 Elsevier Ltd. All rights reserved.